IP Verse

Modernatx patent opposition analysis

Get complete Patent Opposition Report for Modernatx

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest oppositions filed by Modernatx

Explore patent oppositions filed by Modernatx against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent Number	Title	Applicant	Opposition Date
EP2958588	Combination Of Vaccination And Inhibition Of The Pd-1 Pathway	CUREVAC	May 22, 2018
EP2279254	Novel Lipid Formulations For Nucleic Acid Delivery	ARBUTUS BIOPHARMA	Apr 5, 2018

Latest patents of Modernatx opposed by its competitors

Explore Modernatx's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent Number	Grant Date	Title	Total Oppositions
EP3394030	Feb 12, 2025	Compounds And Compositions For Intracellular Delivery Of Agents	1
EP3431485	Sep 4, 2024	Engineered Nucleic Acids And Methods Of Use Thereof	2
EP3917503	May 8, 2024	Methods Of Preparing Lipid Nanoparticles	1
EP3359670	Feb 14, 2024	Methods For Therapeutic Administration Of Messenger Ribonucleic Acid Drugs	1
EP3578652	Jul 12, 2023	Ribonucleic Acid Purification	1
EP3625345	May 24, 2023	Modified Messenger Rna Comprising Functional Rna Elements	2
EP3458083	Nov 2, 2022	Polynucleotides Encoding Interleukin-12 (Il12) And Uses Thereof	2
EP3324979	Oct 12, 2022	Infectious Disease Vaccines	1
EP3590949	May 18, 2022	Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses Thereof	9
EP3718565	Apr 27, 2022	Respiratory Virus Vaccines	4

Top competitors of Modernatx

BIONTECH

WITHERS & ROGERS

PFIZER